Skip to main content

Table 1 Clinical characteristics of the study patients at baseline

From: Enhancement of the serum chloride concentration by administration of sodium–glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: a pilot study

Characteristicsn = 10
Age, years (mean ± SD)61.7 ± 14 (36–92)
Male4
Body mass index (kg/m2)32.1 ± 3.7 (28.2–40)
eGFR (mL min−1·1.73 m−2)76.3 ± 14.4 (51–90)
Cardiovascular disease
 Hypertension7
 Hyperlipidemia6
 Ischemic heart disease1
Medication for cardiovascular disease
 ACE inhibitors/ARB5
 Beta-blockers2
 Calcium antagonists5
 Nitrate1
 Diuretics0
 Lipid-lowering drugs7
Therapy for diabetes
 Metformin5
 Sulfonylureas2
 Dipetidyl peptidase-4 inhibitors7
 Thiazolidinediones0
 Glucagon-like peptide-1 antagonist0
 Insulin2
  1. Data presented as number (%) of patients otherwise specified. eGFR estimated glomerular filtration rate, ACE angiotensin-converting enzyme, ARB angiotensin II receptor blocker